Concepts (160)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Radiology, Interventional | 5 | 2022 | 31 | 1.120 |
Why?
|
| Carcinoma, Hepatocellular | 11 | 2024 | 976 | 1.000 |
Why?
|
| Embolization, Therapeutic | 8 | 2024 | 232 | 0.970 |
Why?
|
| Liver Neoplasms | 9 | 2024 | 1367 | 0.750 |
Why?
|
| Anatomy | 1 | 2017 | 13 | 0.520 |
Why?
|
| Liver Neoplasms, Experimental | 3 | 2024 | 65 | 0.500 |
Why?
|
| Education, Medical, Undergraduate | 1 | 2017 | 178 | 0.430 |
Why?
|
| Chemoembolization, Therapeutic | 2 | 2019 | 23 | 0.430 |
Why?
|
| Radiography, Interventional | 3 | 2020 | 79 | 0.430 |
Why?
|
| Magnetic Resonance Imaging | 7 | 2024 | 3751 | 0.390 |
Why?
|
| Curriculum | 1 | 2017 | 792 | 0.350 |
Why?
|
| Tomography, Spiral Computed | 1 | 2008 | 14 | 0.290 |
Why?
|
| Surgery, Computer-Assisted | 2 | 2022 | 66 | 0.280 |
Why?
|
| Ablation Techniques | 2 | 2019 | 30 | 0.260 |
Why?
|
| Medical Oncology | 2 | 2019 | 243 | 0.260 |
Why?
|
| Contrast Media | 2 | 2022 | 476 | 0.260 |
Why?
|
| Rats, Wistar | 7 | 2024 | 297 | 0.240 |
Why?
|
| Diagnostic Errors | 1 | 2008 | 345 | 0.210 |
Why?
|
| Glypicans | 1 | 2024 | 36 | 0.210 |
Why?
|
| Antibodies, Bispecific | 1 | 2024 | 49 | 0.200 |
Why?
|
| Pelvic Bones | 1 | 2022 | 25 | 0.180 |
Why?
|
| Predictive Value of Tests | 6 | 2020 | 2298 | 0.170 |
Why?
|
| Abdominal Injuries | 1 | 2022 | 123 | 0.170 |
Why?
|
| Specimen Handling | 1 | 2021 | 146 | 0.160 |
Why?
|
| Holography | 1 | 2020 | 1 | 0.160 |
Why?
|
| Acrylic Resins | 1 | 2020 | 7 | 0.160 |
Why?
|
| Gelatin | 1 | 2020 | 16 | 0.160 |
Why?
|
| Gastrointestinal Hemorrhage | 1 | 2023 | 236 | 0.160 |
Why?
|
| Electrolysis | 1 | 2019 | 2 | 0.160 |
Why?
|
| Therapy, Computer-Assisted | 1 | 2020 | 27 | 0.150 |
Why?
|
| Virtual Reality | 1 | 2020 | 34 | 0.150 |
Why?
|
| Angiography, Digital Subtraction | 1 | 2019 | 41 | 0.150 |
Why?
|
| Rats | 6 | 2024 | 3369 | 0.150 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2020 | 253 | 0.150 |
Why?
|
| Viscera | 1 | 2019 | 56 | 0.150 |
Why?
|
| Celiac Artery | 1 | 2019 | 32 | 0.150 |
Why?
|
| CRISPR-Associated Proteins | 1 | 2018 | 9 | 0.140 |
Why?
|
| Aortography | 1 | 2019 | 154 | 0.140 |
Why?
|
| Groin | 1 | 2018 | 14 | 0.140 |
Why?
|
| Femoral Vein | 1 | 2018 | 42 | 0.140 |
Why?
|
| Vascular Remodeling | 1 | 2018 | 46 | 0.140 |
Why?
|
| Radiopharmaceuticals | 1 | 2019 | 155 | 0.140 |
Why?
|
| Gastrostomy | 1 | 2019 | 84 | 0.140 |
Why?
|
| Matrix Metalloproteinase 2 | 1 | 2018 | 86 | 0.140 |
Why?
|
| Graft Occlusion, Vascular | 1 | 2018 | 80 | 0.140 |
Why?
|
| Time Factors | 6 | 2024 | 6168 | 0.130 |
Why?
|
| Optical Imaging | 1 | 2018 | 76 | 0.130 |
Why?
|
| Femoral Artery | 1 | 2018 | 134 | 0.130 |
Why?
|
| Positron-Emission Tomography | 1 | 2019 | 283 | 0.130 |
Why?
|
| Clustered Regularly Interspaced Short Palindromic Repeats | 1 | 2018 | 78 | 0.130 |
Why?
|
| Arteriovenous Shunt, Surgical | 1 | 2018 | 86 | 0.130 |
Why?
|
| Spectroscopy, Near-Infrared | 1 | 2018 | 159 | 0.130 |
Why?
|
| Diethylnitrosamine | 3 | 2024 | 20 | 0.130 |
Why?
|
| Cell Cycle Checkpoints | 1 | 2017 | 59 | 0.130 |
Why?
|
| Periodicals as Topic | 1 | 2019 | 182 | 0.120 |
Why?
|
| Cholecystostomy | 1 | 2016 | 5 | 0.120 |
Why?
|
| Cholecystitis, Acute | 1 | 2016 | 15 | 0.120 |
Why?
|
| Aorta | 1 | 2019 | 521 | 0.120 |
Why?
|
| Magnetic Resonance Imaging, Interventional | 1 | 2015 | 7 | 0.110 |
Why?
|
| Gene Editing | 1 | 2018 | 237 | 0.110 |
Why?
|
| Electroporation | 1 | 2015 | 35 | 0.110 |
Why?
|
| Retrospective Studies | 10 | 2023 | 17650 | 0.110 |
Why?
|
| Cryosurgery | 1 | 2016 | 51 | 0.110 |
Why?
|
| Ascites | 1 | 2016 | 99 | 0.110 |
Why?
|
| CRISPR-Cas Systems | 1 | 2018 | 317 | 0.110 |
Why?
|
| Disease Models, Animal | 4 | 2024 | 4650 | 0.110 |
Why?
|
| Male | 15 | 2025 | 64592 | 0.110 |
Why?
|
| Lung Neoplasms | 1 | 2025 | 1545 | 0.110 |
Why?
|
| Educational Measurement | 1 | 2017 | 319 | 0.110 |
Why?
|
| Humans | 21 | 2025 | 130522 | 0.100 |
Why?
|
| Immunotherapy | 1 | 2019 | 761 | 0.100 |
Why?
|
| Autophagy | 1 | 2017 | 416 | 0.100 |
Why?
|
| Tomography, X-Ray Computed | 4 | 2025 | 2061 | 0.100 |
Why?
|
| Body Weight | 1 | 2017 | 985 | 0.100 |
Why?
|
| Treatment Outcome | 7 | 2025 | 12853 | 0.100 |
Why?
|
| Animals | 11 | 2024 | 33736 | 0.090 |
Why?
|
| Angiography | 2 | 2023 | 179 | 0.090 |
Why?
|
| Biomedical Research | 1 | 2018 | 561 | 0.090 |
Why?
|
| Cell Survival | 2 | 2017 | 825 | 0.090 |
Why?
|
| Endovascular Procedures | 1 | 2020 | 791 | 0.090 |
Why?
|
| Internship and Residency | 1 | 2022 | 1221 | 0.090 |
Why?
|
| Kidney Neoplasms | 1 | 2016 | 420 | 0.090 |
Why?
|
| Aged | 7 | 2025 | 20898 | 0.080 |
Why?
|
| Biopsy | 2 | 2025 | 1229 | 0.080 |
Why?
|
| Liver Transplantation | 1 | 2019 | 1134 | 0.080 |
Why?
|
| Female | 10 | 2025 | 70554 | 0.080 |
Why?
|
| Cell Line, Tumor | 3 | 2024 | 3733 | 0.070 |
Why?
|
| Forecasting | 2 | 2022 | 351 | 0.070 |
Why?
|
| Imaging, Three-Dimensional | 2 | 2022 | 370 | 0.070 |
Why?
|
| Diffusion of Innovation | 2 | 2020 | 83 | 0.070 |
Why?
|
| Fluoroscopy | 2 | 2020 | 107 | 0.070 |
Why?
|
| Middle Aged | 7 | 2025 | 28422 | 0.070 |
Why?
|
| Aged, 80 and over | 4 | 2025 | 6772 | 0.070 |
Why?
|
| Liver | 1 | 2015 | 1788 | 0.070 |
Why?
|
| Image Enhancement | 1 | 2008 | 159 | 0.070 |
Why?
|
| Stress Disorders, Post-Traumatic | 1 | 2014 | 639 | 0.060 |
Why?
|
| Surveys and Questionnaires | 1 | 2017 | 4057 | 0.060 |
Why?
|
| Coronary Artery Disease | 1 | 2014 | 887 | 0.060 |
Why?
|
| Image Interpretation, Computer-Assisted | 1 | 2008 | 229 | 0.060 |
Why?
|
| Models, Animal | 2 | 2019 | 449 | 0.060 |
Why?
|
| Postoperative Complications | 1 | 2019 | 3126 | 0.060 |
Why?
|
| Adult | 4 | 2025 | 31118 | 0.060 |
Why?
|
| Tumor Hypoxia | 1 | 2024 | 7 | 0.050 |
Why?
|
| CD3 Complex | 1 | 2024 | 95 | 0.050 |
Why?
|
| Standard of Care | 1 | 2025 | 131 | 0.050 |
Why?
|
| Necrosis | 1 | 2024 | 192 | 0.050 |
Why?
|
| Bronchoscopy | 1 | 2025 | 178 | 0.050 |
Why?
|
| Societies, Medical | 2 | 2019 | 793 | 0.050 |
Why?
|
| Neoplasms | 1 | 2019 | 2994 | 0.050 |
Why?
|
| Sensitivity and Specificity | 1 | 2008 | 2080 | 0.050 |
Why?
|
| Veterans | 1 | 2014 | 1756 | 0.050 |
Why?
|
| Databases, Factual | 2 | 2019 | 1234 | 0.050 |
Why?
|
| Reproducibility of Results | 1 | 2008 | 2897 | 0.040 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2024 | 1009 | 0.040 |
Why?
|
| Endoscopy, Gastrointestinal | 1 | 2023 | 228 | 0.040 |
Why?
|
| Ergonomics | 1 | 2020 | 24 | 0.040 |
Why?
|
| Radiation Dosage | 1 | 2020 | 132 | 0.040 |
Why?
|
| Radiation Exposure | 1 | 2020 | 45 | 0.040 |
Why?
|
| Electric Conductivity | 1 | 2019 | 79 | 0.040 |
Why?
|
| Role | 1 | 2019 | 27 | 0.040 |
Why?
|
| Radiographic Image Interpretation, Computer-Assisted | 1 | 2020 | 53 | 0.040 |
Why?
|
| Workflow | 1 | 2020 | 141 | 0.040 |
Why?
|
| Cell Death | 1 | 2019 | 224 | 0.040 |
Why?
|
| Portal Vein | 1 | 2019 | 84 | 0.040 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2019 | 409 | 0.040 |
Why?
|
| Phantoms, Imaging | 1 | 2019 | 141 | 0.040 |
Why?
|
| Magnetic Resonance Angiography | 1 | 2019 | 160 | 0.030 |
Why?
|
| Neointima | 1 | 2018 | 48 | 0.030 |
Why?
|
| Vascular Surgical Procedures | 1 | 2023 | 534 | 0.030 |
Why?
|
| Multimodal Imaging | 1 | 2019 | 109 | 0.030 |
Why?
|
| Advisory Committees | 1 | 2018 | 148 | 0.030 |
Why?
|
| Fluorescent Dyes | 1 | 2018 | 246 | 0.030 |
Why?
|
| Equipment Design | 1 | 2019 | 507 | 0.030 |
Why?
|
| Global Health | 1 | 2022 | 623 | 0.030 |
Why?
|
| Waiting Lists | 1 | 2019 | 249 | 0.030 |
Why?
|
| Risk Factors | 3 | 2016 | 11011 | 0.030 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2019 | 1109 | 0.030 |
Why?
|
| Consensus | 1 | 2018 | 521 | 0.030 |
Why?
|
| Fibrosis | 1 | 2017 | 424 | 0.030 |
Why?
|
| Neoplasm, Residual | 1 | 2016 | 133 | 0.030 |
Why?
|
| DNA Damage | 1 | 2018 | 509 | 0.030 |
Why?
|
| Tumor Burden | 1 | 2016 | 238 | 0.030 |
Why?
|
| Education, Medical, Graduate | 1 | 2020 | 552 | 0.030 |
Why?
|
| Disease Progression | 1 | 2019 | 2192 | 0.020 |
Why?
|
| Feasibility Studies | 1 | 2015 | 821 | 0.020 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2019 | 1265 | 0.020 |
Why?
|
| Survival Rate | 1 | 2017 | 2109 | 0.020 |
Why?
|
| Swine | 1 | 2015 | 1183 | 0.020 |
Why?
|
| Coronary Angiography | 1 | 2014 | 449 | 0.020 |
Why?
|
| Renal Dialysis | 1 | 2018 | 948 | 0.020 |
Why?
|
| Pilot Projects | 1 | 2015 | 1440 | 0.020 |
Why?
|
| Prospective Studies | 1 | 2021 | 6424 | 0.020 |
Why?
|
| Gene Expression Regulation | 1 | 2018 | 2320 | 0.020 |
Why?
|
| Biomarkers | 1 | 2018 | 3365 | 0.020 |
Why?
|
| Mice | 1 | 2024 | 18202 | 0.020 |
Why?
|
| Prevalence | 1 | 2014 | 2692 | 0.020 |
Why?
|
| Antineoplastic Agents | 1 | 2015 | 1814 | 0.010 |
Why?
|
| Young Adult | 1 | 2019 | 10035 | 0.010 |
Why?
|
| Adolescent | 1 | 2019 | 20877 | 0.010 |
Why?
|
| United States | 1 | 2014 | 12009 | 0.010 |
Why?
|